Windtree Therapeutics, Inc. ( WINT) - Stock Earnings
WINT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| June 17, 2026 AfterMarket | — / — | — | — / — | — |
WINT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -4.0 million USD | 90000 USD |
| 2025Q2 | -10.6 million USD | — USD |
| 2025Q3 | -28.1 million USD | — USD |
WINT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -39.2 million USD | — USD |
| 2023 | -20.3 million USD | — USD |
| 2024 | -5.5 million USD | — USD |
| 2026 Est. | — | — |
WINT
Price: $0.02
52 week price:
Payout Ratio Range:
Earnings Per Share: 323.08 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 214600
Market Capitalization: 674175